SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (10662)11/3/1997 9:28:00 AM
From: Beverly M  Read Replies (2) | Respond to of 32384
 
Henry, yes, and I'm real anxious to see if that benefits LGND or drags it down!

Bev



To: Henry Niman who wrote (10662)11/3/1997 9:29:00 AM
From: Arthur Radley  Read Replies (4) | Respond to of 32384
 
Henry,
What impact do you think this WLA news will have for LGND/LLY?



To: Henry Niman who wrote (10662)11/3/1997 9:31:00 AM
From: David Bogdanoff  Read Replies (2) | Respond to of 32384
 
Henry;

I also heard the CNBC announcement on liver problems for Rezulin. Is this complete unexpected news? It looks serious to me.
Does anyone have any more specific information, like the source of the reports, the number of patients involved, possible FDA or company action?

David


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News